Atlanta Capital Management Co L L C / TMO
Atlanta Capital Management Co L L C’s Thermo Fisher Scientific Inc Position
Does Atlanta Capital Management Co L L C own Thermo Fisher Scientific Inc (TMO)? Yes — 802.3K shares worth $407M (+1.81% of its 13F portfolio) as of Q3 2022, up from 759.5K shares the prior filed quarter.
Position Value
$407M
Q3 2022
Shares
802.3K
% of Portfolio
+1.81%
Quarters Held
16
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 802.3K | $407M | +1.81% |
| Q2 2022 | 759.5K | $413M | +1.78% |
| Q1 2022 | 814.3K | $481M | +1.78% |
| Q4 2021 | 810.2K | $541M | +1.83% |
| Q3 2021 | 830.9K | $475M | +1.70% |
| Q2 2021 | 922.8K | $466M | +1.61% |
| Q1 2021 | 916.9K | $418M | +1.48% |
| Q4 2020 | 1.00M | $467M | +1.67% |
| Q3 2020 | 1.05M | $464M | +1.91% |
| Q2 2020 | 1.12M | $405M | +1.71% |
| Q1 2020 | 1.06M | $299M | +1.56% |
| Q4 2019 | 988.0K | $321M | +1.33% |
| Q3 2019 | 907.9K | $264M | +1.15% |
| Q2 2019 | 828.0K | $243M | +1.09% |
| Q1 2019 | 812.1K | $222M | +1.06% |
| Q4 2018 | 792.5K | $177M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlanta Capital Management Co L L C’s full portfolio or all institutional holders of TMO.